Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer's disease

Brain Research

Volumn 887, Issue 1, 2000, Pages 80-89

  Yasojima, Koji ^a   Schwab, Claudia ^a   McGeer, Edith G ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cerebellum; Entorhinal cortex; Hippocampus; Immunohistochemistry; In situ hybridization; Liver; mRNA; Pentraxin; Pyramidal neuron; Western blot

Indexed keywords

AMYLOID P COMPONENT; C REACTIVE PROTEIN; MESSENGER RNA; PENTRAXIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PYRAMIDAL NERVE CELL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; BRAIN CHEMISTRY; C-REACTIVE PROTEIN; CYCLOPHILINS; FEMALE; HUMANS; LIVER; MALE; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM AMYLOID P-COMPONENT;

EID: 0034704261     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02970-X     Document Type: Article

References (43)

1. Association of amyloid P component with complement proteins in neurologically diseased tissue
2. Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects
3. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis
4. Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted Turbo-FLASH imaging
5. Expression of C-reactive protein by alveolar macrophages
6. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease
7. Immunodetection of the amyloid P component in Alzheimer's disease
8. Acute-phase proteins and other systemic responses to inflammation
9. Structure and function of the pentraxins
10. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis
11. Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease
12. Serum amyloid P component binds to histones and activates the classical complement pathway
13. A simple sequentially repetitive multiple test procedure
14. A case of familial, atypical Alzheimer's disease: Immunohistochemical study of amyloid P-component
15. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections
16. Extensive postmortem stability of RNA from rat and human brain
17. Serum amyloid P in Alzheimer's disease: Implications for dysfunction of the blood-brain barrier
18. Levels of interleukin-6, CRP and α2-macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damage
19. C-reactive protein as a cardiovascular risk factor
20. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction
21. The chemistry, biology, and phylogeny of C3
22. 123I-serum amyloid P component in Alzheimer disease
23. Autotoxicity and Alzheimer disease
24. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological studies
25. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II: Standardization of pathothologic assessment of Alzheimer's disease
26. The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain
27. C-Reactive protein and outcome after ischemic stroke
28. Amyloid P component and the diagnosis of amyloidosis
29. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment
30. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
31. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography
32. Amyloid P immunoreactivity precedes C4d deposition on extracellular neuro-fibrillary tangles
33. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
34. The use of cytokine and C-reactive protein measurements in cerebrospinal fluid during acute infective meningitis
35. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
36. C-Reactive protein: Structural biology, gene expression and host defense function
37. Neurons express proteins of the classical complement pathway in Alzheimer disease
38. C-Reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
39. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease
40. CRP-mediated activation of complement in vivo
41. Human heart generates complement proteins that are upregulated and activated after myocardial infarction
42. Upregulated production and activation of the complement system in Alzheimer disease brain
43. Characterization of the binding of serum amyloid P to laminin